本文已被:浏览 53次 下载 15次
投稿时间:2026-01-16 网络发布日期:2026-05-01
投稿时间:2026-01-16 网络发布日期:2026-05-01
中文摘要: 目的 系统评价和比较免疫功能正常患者的结节型肺隐球菌病内科保守治疗与外科治疗的临床疗效和预后。 方法 回顾性纳入2015年9月至2023年8月于江苏省中医院确诊并接受治疗的孤立性结节型肺隐球菌病59例患者。 收集患者一般资料、系列胸部影像学特征及血清荚膜多糖抗原(CrAg)变化,按照治疗方法分为两组,以内科治疗组(27例,口服氟康唑400 mg/d)治疗6个月、停药6个月为随访1、随访2;对应地以外科治疗组(32例,行楔形切除手术切除肺部病灶)术后6个月、1年为随访1、随访2,综合评估其近期与远期治疗反应。 单组重复测量资料的连续变量采用重复测量方差分析,两组重复测量的分类变量采用广义估计方程分析。 结果 两组患者性别、病灶位置、病灶最大径及治疗前血清CrAg阳性率等差异均无统计学意义(P>0.05)。(1)内科治疗组:随访1、随访2时影像学评估显示,病灶达影像学完全缓解仅4例(14.8%)。重复测量方差分析结果显示,病灶直径在基线[(1.85±0.76)cm]、随访1[(1.27±0.80)cm]和随访2[(1.26±0.77)cm]总体比较差异有统计学意义(F= 17.278,P<0.01),随访1、随访2时较基线显著缩小(P<0.01)。三个时点血清 CrAg阳性率差异无统计学意义(P>0.05)。(2)外科治疗组:术后随访期间手术部位及其他肺野未出现新发结节;术后血清CrAg逐次转阴,并于随访2时达93.75%(30/32)。(3)组间比较:外科治疗组血清CrAg阳性率在随访1(15.63% vs 74.07%,χ2=20.488,P<0.01)和随访2时(6.25% vs 70.37%,χ2=26.264,P<0.01)均显著低于内科治疗组。 结论 对于免疫功能正常的结节型肺隐球菌病患者,6个月的内科抗真菌治疗虽可使病灶部分缩小,但影像学完全缓解率低,且血清学指标阴转率低。 相比之下,外科手术能彻底清除病灶,血清CrAg 在1年内大部转阴,且无复发,显示出更彻底的疾病控制效果。
Abstract:Objective To systematically evaluate and compare the clinical efficacy and prognosis of medical conservative therapy versus surgical treatment for nodular pulmonary cryptococcosis in immunocompetent patients. Methods A retrospective study included 59 patients with solitary nodular pulmonary cryptococcosis who were diagnosed and treated at Jiangsu Provincial Hospital of Chinese Medicine from September 2015 to August 2023. The general data, serial chest imaging features and changes of serum capsular polysaccharide antigen(CrAg) were collected. The patients were divided into two groups according to the treatments. For the medical treatment group(27 cases,treated with oral fluconazole 400 mg/d),follow-up 1 and follow-up 2 were at 6 months of treatment and 6 months after discontinuation,respectively;correspondingly,for the surgical treatment group(32 cases,undergoing wedge resection to remove pulmonary lesions),follow-up 1 and follow-up 2 were at 6 months and 1 year post-surgery, respectively,to comprehensively evaluate their short - term and long - term treatment responses. Continuous variables from single-group repeated measurements were analyzed using the repeated measures ANOVA,and categorical variables from two-group repeated measurements were analyzed using generalized estimating equations. Results There were no statistically significant difference between the two groups of patients in terms of gender,lesion location,maximum lesion diameter, and pre - treatment serum CrAg positivity rate(P>0.05).(1)Medicine treatment group:imaging evaluation at follow-up 1,follow-up 2 showed that only 4 cases(14. 8%)achieved complete radiological remission. The repeated measures ANOVA test showed that there was a statistically significant overall difference in lesion diameters at baseline[(1.85±0.76)cm],follow-up 1[(1.27±0. 80)cm],and follow-up 2[(1.26±0.77)cm](F= 17.278,P<0.01), with diameters at both follow-up 1 and follow-up 2 being lower than at baseline(P<0.01). The positive rate of serum CrAg did not change significantly across the three time points( P>0.05).(2)Surgical treatment group: during postoperative follow- up,no new nodule appeared at the surgical site or other lung fields;postoperative serum CrAg gradually turned negative,with 93.75%(30/32)at follow-up 2.(3)Inter-group comparison:the positive rate of serum CrAg in the surgical treatment group was significantly lower than that in the medical treatment group at both follow-up 1(15.63% vs 74.07%,χ2=20.488,P<0.01)and follow-up 2(6.25% vs 70.37%,χ2=26.264,P<0.01). Conclusion For immunocompetent patients with nodular pulmonary cryptococcosis,a 6-month course of medical antifungal therapy can partially reduce the lesions,but yields low rates of complete radiological resolution and seroconversion of CrAg. In contrast,surgical intervention can achieve complete lesion eradication,with seroconversion of CrAg in most cases within one year and no recurrence,indicating a more thorough disease control effect.
keywords: Pulmonary cryptococcosis,nodular type Fluconazole Immune function Capsular polysaccharide antigen Medical imaging
文章编号: 中图分类号:R519.4 R45 文献标志码:A
基金项目:国家自然科学基金青年基金(82405312)
附件
引用文本:
吕晓静,王志超,王晓,等.免疫功能正常结节型肺隐球菌病患者内外科治疗选择[J].中国临床研究,2026,39(4):603-608.
吕晓静,王志超,王晓,等.免疫功能正常结节型肺隐球菌病患者内外科治疗选择[J].中国临床研究,2026,39(4):603-608.
